Results 101 to 110 of about 58,715 (292)
Rifaximin Treatment in Hepatic Encephalopathy
Background Hepatic encephalopathy is a chronically debilitating complication of hepatic cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the treatment of acute hepatic encephalopathy, but its efficacy for ...
Frederick, Todd +16 more
core +1 more source
CN‐TIPS is a nationwide, multicenter prospective registry that will enroll 10,000 adults with portal hypertension undergoing transjugular intrahepatic portosystemic shunt in China, integrating perioperative clinical and hemodynamic metrics with standardized imaging (including computational modeling in a dedicated subcohort) and multi‐omics biospecimens,
Yi Xiang +20 more
wiley +1 more source
Introduction and aim. The evaluation to determine the cause of hepatic encephalopathy consists primarily of laboratory testing to rule out infections and metabolic causes.
Sumit Kumar +4 more
doaj +1 more source
Minimal hepatic encephalopathy: Characteristics and comparison of the main diagnostic modalities
According to the latest clinical guidelines, minimal hepatic encephalopathy (MHE) is diagnosed by using a single test for which the center has experience and local norms. Nowadays, several tests are available.
Mariana P. Radicheva +2 more
core +1 more source
In patients with acute‐on‐chronic liver failure (ACLF), esophagogastric variceal bleeding (EGVB) represents a critical complication associated with high short‐term mortality. This study evaluated the efficacy of endoscopic treatment in this specific population and identified prognostic factors associated with 6‐week rebleeding and mortality.
Yanan Sun +7 more
wiley +1 more source
Introduction. Hyponatremia is associated with high mortality and predicts hepatic encephalopathy but its effect on health-related quality of life remains to be established.Material and methods.
Ewa Wunsch +5 more
doaj +1 more source
The why and wherefore of hepatic encephalopathy
Vijay PB Grover, Joshua M Tognarelli, Nicolas Massie, Mary ME Crossey, Nicola A Cook, Simon D Taylor-Robinson Liver Unit, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, London, UK Abstract: Hepatic ...
Tognarelli JM +5 more
core
A Case of Ileal Conduit Bleeding Caused by Porto‐Sinusoidal Vascular Disorder
ABSTRACT A 60‐year‐old man presented with recurrent stomal bleeding for 3 years. He had undergone cystoprostatectomy with ileal conduit diversion for bladder cancer 7 years prior. Endoscopy revealed multiple protruding lesions (0.6–0.8 cm) inside the stoma, which were initially suspected to be ectopic varices given concomitant esophageal varices and ...
Lu Yu, Hao Wu, Huan Tong
wiley +1 more source
This preclinical study evaluated a novel controlled‐expansion expanded polytetrafluoroethylene (ePTFE)‐covered transjugular intrahepatic portosystemic shunt (TIPS) stent in 11 swine, demonstrating 100% technical success, excellent deployability, and durable 6‐month angiographic patency without thrombosis, migration, fracture, or device‐related toxicity.
Yi Xiang +15 more
wiley +1 more source
Neurobehavioral Tests in Preclinical Studies of Hepatic Encephalopathy
Hepatic encephalopathy (HE) is a complex neuropsychiatric disorder that arises as result of liver dysfunction. HE encompasses a wide range of neurological and neuropsychiatric abnormalities ranging from subclinical changes to coma. It can be divided into
El-Mansoury, Bilal +3 more
core +1 more source

